Nuclear Medicine Imaging Tools in Fever of Unknown Origin: Time for a Revisit and Appropriate Use Criteria
Clinical Infectious Diseases · 15.05.2024 · 78 (5) · 1148-1153
DOI: 10.1093/cid/ciae115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 05.03.2024. Verfasst von William F Wright und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Fever of Unknown Origin, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Nuclear Medicine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIBIB NIH HHS, Johns Hopkins Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.
Abstract (Originalsprache)
Fever of unknown origin (FUO) is a clinical conundrum for patients and clinicians alike, and imaging studies are often performed as part of the diagnostic workup of these patients. Recently, the Society of Nuclear Medicine and Molecular Imaging convened and approved a guideline on the use of nuclear medicine tools for FUO. The guidelines support the use of 2-18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) in adults and children with FUO. 18F-FDG PET/CT allows detection and localization of foci of hypermetabolic lesions with high sensitivity because of the 18F-FDG uptake in glycolytically active cells that may represent inflammation, infection, or neoplasia. Clinicians should consider and insurers should cover 18F-FDG PET/CT when evaluating patients with FUO, particularly when other clinical clues and preliminary studies are unrevealing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Division of Infectious Diseases, Emory University Hospital, Atlanta, Georgia, USA.
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Radiology, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
- Center for Infection and Inflammation Imaging Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Sanjay K Jain
Förderung
- NIAID NIH HHS
- NIBIB NIH HHS
- Johns Hopkins Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
- NIH HHS
- NCATS NIH HHS
- Johns Hopkins Institute for Clinical and Translational Research
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Wright, W. F., Kandiah, S., Brady, R., Shulkin, B. L., Palestro, C. J., & Jain, S. K. (2024). Nuclear Medicine Imaging Tools in Fever of Unknown Origin: Time for a Revisit and Appropriate Use Criteria. Clinical Infectious Diseases, 78(5), 1148-1153. https://doi.org/10.1093/cid/ciae115
Vancouver
Wright WF, Kandiah S, Brady R, Shulkin BL, Palestro CJ, Jain SK. Nuclear Medicine Imaging Tools in Fever of Unknown Origin: Time for a Revisit and Appropriate Use Criteria. Clinical Infectious Diseases. 2024;78(5):1148-1153. doi:10.1093/cid/ciae115
BibTeX
@article{Wright2024,
author = {Wright, William F and Kandiah, Sheetal and Brady, Rebecca and Shulkin, Barry L and Palestro, Christopher J and Jain, Sanjay K},
title = {Nuclear Medicine Imaging Tools in Fever of Unknown Origin: Time for a Revisit and Appropriate Use Criteria},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {78},
number = {5},
pages = {1148--1153},
doi = {10.1093/cid/ciae115}
}
EUVIMED